Whitton J L
Department of Neuropharmacology, Scripps Research Institute, La Jolla, California 92037.
Adv Virus Res. 1994;44:267-303. doi: 10.1016/s0065-3527(08)60331-0.
In this chapter I have attempted to outline the rationale that underlies the antisense approach to treatment of virus infection, to catalog the effector molecules that are currently available, and to estimate the relative worth of each. In so doing I have tried to describe the criteria that might be employed in their design and the factors that may determine their efficacy in tissue culture and, perhaps, in vivo. Finally, I have described the few examples presently available that indicate that antisense approaches may one day be therapeutically useful in treatment of disease of viral or nonviral origin.
在本章中,我试图概述反义疗法治疗病毒感染背后的基本原理,列举目前可用的效应分子,并评估每种分子的相对价值。在此过程中,我试图描述其设计中可能采用的标准以及可能决定其在组织培养中乃至体内疗效的因素。最后,我介绍了目前为数不多的实例,这些实例表明反义疗法可能有朝一日在治疗病毒或非病毒源性疾病方面具有治疗价值。